Genflow Biosciences plc (LON:GENF)
London · Delayed Price · Currency is GBP · Price in GBX 2.660
-0.300 (-10.14%)
May 6, 2026, 4:35 PM GMT
Genflow Biosciences Market Cap
Genflow Biosciences has a market cap or net worth of 15.86 million as of May 6, 2026. Its market cap has increased by 268.60% in one year.
Market Cap
15.86M
Enterprise Value
15.74M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
2.66
Market Cap Chart
Since January 17, 2022, Genflow Biosciences's market cap has decreased from 33.64M to 15.86M, a decrease of -52.87%. That is a compound annual growth rate of -16.05%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 15.86M | 73.65% |
| Dec 31, 2025 | 9.13M | 51.36% |
| Dec 31, 2024 | 6.03M | 44.72% |
| Dec 29, 2023 | 4.17M | -40.63% |
| Dec 30, 2022 | 7.02M | -79.13% |
| Jan 17, 2022 | 33.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Poolbeg Pharma | 31.73M |
| Sareum Holdings | 27.96M |
| SkinBioTherapeutics | 25.27M |
| ImmuPharma | 24.96M |
| Arecor Therapeutics | 24.92M |
| Aptamer Group | 20.73M |
| Fusion Antibodies | 15.63M |
| IXICO | 14.99M |